Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy. - Cox, Timothy M.; Drelichman, Guillermo; Balwani, Manisha; Burrow, Thomas Andrew; Lukina, Elena; Rosenbloom, Barry; Gaemers, Sebastiaan J.M.; Angell, Jennifer; Judith Peterschmitt, M. (Molecular Genetics & Metabolism, 2016)